Background: Telemedicine for people with type 2 diabetes (T2D) has the potential to positively impact self-management behaviors and improve health outcomes. The Onduo Virtual Diabetes Clinic (VDC) is a comprehensive telehealth program for people with T2D that combines mobile app technology, remote personalized lifestyle coaching from certified diabetes educators and health coaches, connected devices including blood glucose meters and continuous glucose monitoring systems, and clinical support from board certified endocrinologists.
Results: Participants (n=740) were (mean ± SD): 53.8 ± 8.8 years of age, 62% female, BMI 35.6 ± 8.5, initial HbA 1c 7.7% ± 1.8, 31.0% were on insulin and 25.9% were on sulfonylureas at baseline, and 30.0% lived in a rural area. HbA 1c decreased significantly by 2.3% ± 1.9, 0.7% ± 1.0 and 0.2% ± 0.8 across the baseline categories of >9.0%, 8.0% to 9.0% and 7.0% to <8.0%, respectively (all P<.001). Within these categories, HbA 1c improved in 91.9%, 77.3% and 63.5% of participants. For the group with an initial HbA 1c >9.0%, HbA 1c decreased from 10.7% ± 1.4 to 8.3% ± 1.5, and when stratified by HbA 1c ≥8.0% the mean decrease in HbA 1c was 1.5%, from 9.5% ± 1.5 to 8.0% ± 1.3, with 84.5% of participants demonstrating improvement. Participants with an initial HbA 1c <7.0% who were meeting treatment targets at baseline, HbA 1c 6.3% ± 0.4, continued to maintain this level of glycemic control at follow-up, HbA 1c 6.4% ± 0.6 (ns).
Conclusions:
Participation in the VDC was associated with a significant improvement in HbA 1c in adults with T2D who were not meeting treatment targets, with the greatest improvement observed in those with an initial HbA 1c >9.0%. Importantly, the majority of program participants experienced an improvement in glycemic control. Our findings suggest that the VDC program is an effective approach to support individuals with T2D and their clinicians in diabetes management between office visits. 2019;5(1):e15258) 
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